Palivizumab in the prevention of severe respiratory syncytial virus infection in children… https://t.co/Mh3iS6xc23
24,378 followers
2,181 followers
Palivizumab in the prevention of severe respiratory syncytial virus infection in children with congenital heart disease; a novel cost-utility modeling study reflecting evidence-based clinical pathways in Spain https://t.co/esTEDVjmgS https://t.co/WhLeqxex4
721 followers
#HealthEconJA Palivizumab in the prevention of severe respiratory syncytial virus infection in children with congenital heart disease; a novel cost-utility modeling study reflecting evidence-based clinical pathways in Spain https://t.co/plTV0k4Zv1